FORM 10-QSB
                         SECURITIES EXCHANGE COMMISSION
                             Washington, D.C. 20549


[ X] Quarterly  Report under Section 13 or 15(d) of the Securities  Exchange Act
of 1934 For Quarterly Period Ended December 31, 2005

[ ]  Transition  Report  under  Section 13 or 15(d) of the  Exchange Act For the
Transition period from _______________ to ______________

                        Commission file number: 000-29621

                                   XSUNX, INC.
                       ---------------------------------
             (Exact name of registrant as specified in its charter)


               Colorado                           84-1384159
        ---------------------           ---------------------------------
      (State of incorporation)         (I.R.S. Employer Identification No.)


                      65 Enterprise, Aliso Viejo, CA 92656
                      ------------------------------------
               (Address of principal executive offices) (Zip Code)

                  Registrant's telephone number: (949) 330-8060


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2)  has  been  subject  to the  filing
requirements for at least the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the  Registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).

                                      [   ]  Yes                [ X ] No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

As of February  20, 2006 the number of shares  outstanding  of the  registrant's
only class of common stock was 127,417,080.

Transitional Small Business Disclosure Format (check one): Yes [_] No [X]








                                Table of Contents


PART I - FINANCIAL INFORMATION                                                                           PAGE
                                                                                                         ----

                                                                                                       
Item 1.  Financial Statements....................................................................         2

         Independent Auditor's Report............................................................         F-1

         Balance Sheets December 31, 2005 (unaudited) and September 30, 2005.....................         F-2

         Statements of Operations  for the Three Months ended  December 31, 2005
         and 2004 (unaudited) and the period February 25, 1997 (inception)
         to December 31, 2005....................................................................         F-3

         Statements of Stockholders Equity for the period February 25, 1997
         (inception) to December 31, 2005 unaudited).............................................         F-5

         Statements  of Cash Flows for the Three Months ended  December 31, 2005
         and 2004  (unaudited) and the period  February 27, 1997  (inception) to
         December 31, 2005.......................................................................         F-9

         Notes to Financial Statements
         (Unaudited).............................................................................         F-10

Item 2.  Management's Discussion and Analysis of Financial Condition and
                  Results of Operations..........................................................         3

Item 3. Controls and Procedures..................................................................         7

PART II - OTHER INFORMATION

Item 1.  Legal Proceedings......................................................................          7

Item 2.  Changes in Securities...................................................................         7

Item 3.  Defaults upon Senior Securities.........................................................         8

Item 4.  Submission of Matters to a Vote of Security Holders.....................................         8

Item 5.  Other Information ......................................................................         8

Item 6.  Exhibits and Reports on Form 8-K........................................................         8

Signatures.......................................................................................         9



                                       1




                          PART I. FINANCIAL INFORMATION

Item 1.  FINANCIAL STATEMENTS

                                   XSUNX, INC.

                          (A DEVELOPMENT STAGE COMPANY)
                              FINANCIAL STATEMENTS

                      THREE-MONTHS ENDED DECEMBER 31, 2005
                                   (UNAUDITED)






























                                       2





JASPERS + HALL, PC
CERTIFIED PUBLIC ACCOUNTANTS
--------------------------------------------------------------------------------
9175 E. Kenyon Avenue, Suite 100
Denver, CO 80237
303-796-0099



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Board of Directors
XSUNX, INC.
Aliso Viejo, CA


We have reviewed the  accompanying  balance sheet of XSUNX,  INC. (a development
stage  company)  as  of  December  31,  2005,  and  the  related  statements  of
operations,  stockholders' equity (deficit),  and cash flows for the three-month
period then ended.  These  financial  statements are the  responsibility  of the
Company's management.

We conducted  our review in  accordance  with  standards  of the Public  Company
Accounting  Oversight  Board (United  States).  The review of interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with standards of the Public Company Accounting Oversight Board (United States),
the  objective  of  which  is  the  expression  of  an  opinion   regarding  the
consolidated  financial  statements  taken  as a whole.  Accordingly,  we do not
express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the  accompanying  financial  statements for them to be in conformity
with accounting principles generally accepted in the United States.

The  accompanying  financial  statements  have been  prepared  assuming that the
Company will  continue as a going  concern.  As discussed in Note 2,  conditions
exist which raise substantial doubt about the Company's ability to continue as a
going  concern.  Management's  plans in regard to these matters are described in
Note 2. The  financial  statements  do not  include any  adjustments  that might
result from the outcome of this uncertainty.


/s/Jaspers + Hall, PC
---------------------------
Jaspers + Hall, PC
Denver, CO
February 13, 2006







                                       F-1







                                   XSUNX, INC.
                          (A Development Stage Company)
                                 BALANCE SHEETS
                                   (Unaudited)

                                                                                        December 31,         September 30,
                                                                                            2005                 2005
                                                                                      -----------------    ------------------
ASSETS:
Current assets:
                                                                                                     
   Cash                                                                               $      1,278,163     $         175,869

   Accounts Receivable                                                                           8,000                     -

   Prepaid Expenses                                                                            300,946                79,984
                                                                                      -----------------    ------------------

      Total current assets                                                                   1,587,109               255,853
                                                                                      -----------------    ------------------

Fixed assets:
   Office Equipment                                                                            165,831               165,831
                                                                                      -----------------    ------------------

       Total fixed assets                                                                      165,831               165,831
                                                                                      -----------------    ------------------

Other assets:

    Patents                                                                                     20,000                20,000
                                                                                      -----------------    ------------------


      Total other assets                                                                        20,000                20,000
                                                                                      -----------------    ------------------

TOTAL ASSETS                                                                          $      1,772,940     $         441,684
                                                                                      =================    ==================


LIABILITIES AND STOCKHOLDERS' EQUITY:
Current Liabilities:
   Accounts Payable                                                                   $         26,636     $          78,377

   Accrued Expenses                                                                             65,636                45,856
   Notes Payable                                                                             2,850,000               850,000
                                                                                      -----------------    ------------------

     Total current liabilities                                                               2,942,272               974,233
                                                                                      -----------------    ------------------

Stockholders' Equity:
Preferred Stock, par value $0.01 per share; 50,000,000
 shares authorized; no shares issued and outstanding                                                 -                     -

Treasury Stock, no par value; 26,798,418 issued and outstanding                                      -                     -
Common Stock, no par value; 500,000,000 shares authorized;
  123,917,080 shares issued and outstanding at December 31, 2005
  and 123,876,633 shares issued and outstanding at September 30, 2005                        4,004,235             3,996,735
Common Stock Warrants                                                                        2,151,250             1,200,000
Deficit accumulated during the development stage                                           (7,324,817)           (5,729,284)
                                                                                      -----------------    ------------------
      Total stockholders' profit (deficit)                                                 (1,169,332)             (532,549)
                                                                                      -----------------    ------------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                                            $      1,772,940     $         441,684
                                                                                      =================    ==================

                         See Accountants' Review Report
                                       F-2







                                   XSUNX, INC.
                          (A Development Stage Company)
                             STATEMENT OF OPERATIONS
                                   (Unaudited)

                                                    Three-Months Ended                Feb. 25, 1997
                                                       December 31,                   (Inception) to
                                            ------------------------------------        December 31,
                                                 2005                 2004                 2005
                                            ----------------     ---------------     ------------------

Revenue
                                                                            
   Service Income                           $         8,000      $            -      $           8,000

   Other Income                                           -                   -                      -
                                            ----------------     ---------------     ------------------


Total Revenue                                         8,000                   -                  8,000
                                            ----------------     ---------------     ------------------

Expenses:

   Abandoned Equipment                                    -                   -                    808

   Advertising                                          349               1,860                  4,328

   Bank Charges                                          64                 190                  2,677

   Conferences & Seminars                             1,500                   -                  1,500

   Consulting                                             -                   -              1,344,983

   Depreciation                                           -                   -                 21,613

   Directors' Fees                                        -                   -                 11,983

   Due Diligence                                          -                   -                 45,832

   Equipment Rental                                       -                   -                  1,733

   Filing Fees                                            -                   -                  1,800

   Impairment loss                                        -                   -                923,834

   Insurance                                              -                   -                    758

   Legal & Accounting                                33,750               9,124                329,359

   Licenses & Fees                                        -                   -                  6,435

   Loan Fees                                        213,000                   -                328,000

   Meals & Entertainment                                  -                   -                  4,119

   Miscellaneous                                        800                                      2,475

   Office Expenses                                    1,473               1,405                 23,306

   Patent Fees                                            -                   -                    663

   Postage & Shipping                                   458                 174                  5,836

   Printing                                           2,943                  39                 12,823

   Public Relations                                  33,352               7,189                260,731

   Research & Development                           274,603              98,897                905,519

   Rent                                               2,250               1,500                 28,213

   Salaries                                          44,229              40,885                699,551

   Subscription Reports                                  85                                        945

   Taxes                                                  -                   -                  4,657

   Telephone                                          1,390               1,004                 41,694

   Transfer Agent Expense                                 -               1,759                 19,954

   Travel                                             4,860                 961                 79,027

   Warrant Option Expense                           951,250                   -              2,151,250
                                            ----------------     ---------------     ------------------

Total Operating Expenses                          1,566,356             164,987              7,266,406
                                            ----------------     ---------------     ------------------



                         See Accountants' Review Report
                                       F-3






                                   XSUNX, INC.
                          (A Development Stage Company)
                             STATEMENT OF OPERATIONS
                                   (Unaudited)

                                   (continued)


                                                    Three-Months Ended                Feb. 25, 1997
                                                       December 31,                   (Inception) to
                                                 -------------------------             December 31,
                                                 2005                 2004                 2005
                                                 ----                 ----                 ----

Other Income (Expense)

                                                                             
   Interest Expense                                  37,177                   -                126,207

   Interest Income                                        -                   -                   (23)

   Forgiveness of Debt                                    -                   -               (59,773)
                                            ----------------     ---------------     ------------------


Total Other Income/Expense                           37,177                   -                 66,411
                                            ----------------     ---------------     ------------------

Net (Loss)                                  $   (1,595,533)      $    (164,987)      $     (7,324,817)
                                            ================     ===============     ==================


Per Share Information:

   Weighted average number of
     common shares outstanding                  123,888,194         114,036,102
                                            ================     ===============

Net Loss per Common Share                   $        (0.01)                   *
                                            ================     ===============

* Less than $.01


















                         See Accountants' Review Report
                                       F-4





                                                             XSUNX, INC.
                                                    (A Development Stage Company)
                                             STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
                                                          December 31, 2005

                                                             (Unaudited)


                                                                                                             Deficit
                                                                                                            Accumulated
                                           Treasury Stock                Common Stock          Common       During the
                                      --------------------------    -----------------------    Stock        Exploration
                                       # of Shares     Amount       # of Shares   Amount       Warrants       Stage        Totals
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

                                                                                                    
Inception February 25, 1997                     -              -              -          -              -            -           -

Issuance of stock for cash 3/97                 -              -         10,590    111,900              -            -     111,900
Issuance of stock to Founders 3/97              -              -         14,110          -              -            -           -
Issuance of stock for consolidation 4/97        -              -        445,000    312,106              -            -     312,106
Issuance of stock for cash 8/97                 -              -          2,900     58,000              -            -      58,000
Issuance of stock for cash 9/97                 -              -          2,390     47,800              -            -      47,800
Net Loss for Year                               -              -              -          -              -    (193,973)   (193,973)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 1997                    -              -        474,990    529,806              -    (193,973)     335,833
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Issuance of stock for services 11/97            -              -          1,500     30,000              -            -      30,000
Issuance of stock for cash 9/98                 -              -         50,200    204,000              -            -     204,000
Consolidation stock cancelled 9/98              -              -       (60,000)   (50,000)              -            -    (50,000)
Net Loss for Year                               -              -              -          -              -    (799,451)   (799,451)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 1998                    -              -        466,690    713,806              -    (993,424    (279,618)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

                                                  See Accountants' Review Report
                                                                F-5




                                                             XSUNX, INC.
                                                    (A Development Stage Company)
                                             STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
                                                          December 31, 2005

                                                             (Unaudited)

                                                                                                             Deficit
                                                                                                            Accumulated
                                           Treasury Stock                Common Stock          Common       During the
                                      --------------------------    -----------------------    Stock        Exploration
                                       # of Shares     Amount       # of Shares   Amount       Warrants       Stage        Totals
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------
                                                                                                    
Issuance of stock for cash 10/98                -              -         21,233    159,367              -            -     159,367
Issuance of stock for services 1/99             -              -         65,000    316,500              -            -     316,500
Issuance of stock for cash 1/99                 -              -         37,500    296,125              -            -     296,125
Issuance of stock for cash 2/99                 -              -          7,500     70,313              -            -      70,313
Issuance of stock for cash 4/99                 -              -         45,225    122,108              -            -     122,108
Issuance of stock for services 6/99             -              -         70,000    147,000              -            -     147,000
Issuance of stock for cash 9/99                 -              -         40,000     69,200              -            -      69,200
Net Loss for Year                               -              -              -          -              -   (1,482,017) (1,482,017)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 1999                    -              -        753,148  1,894,419              -   (2,475,441)   (581,022)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Issuance of stock for cash 9/00                 -              -         15,000     27,000              -            -      27,000
Net Loss for year                               -              -              -          -              -     (118,369)   (118,369)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 2000                    -              -        768,148  1,921,419              -   (2,593,810)   (672,391)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Extinquishment of debt                          -              -              -    337,887              -            -     337,887
Net Loss for year                               -              -              -          -              -      (32,402)    (32,402)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 2001                    -              -        768,148  2,259,306              -   (2,626,212)   (366,906)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Net Loss for year                               -              -              -           -             -      (47,297)    (47,297)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 2002                    -              -        768,148   2,259,306             -   (2,673,509)   (414,203)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------



                                                  See Accountants' Review Report
                                                                F-6



                                                             XSUNX, INC.
                                                    (A Development Stage Company)
                                             STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
                                                          December 31, 2005

                                                             (Unaudited)

                                                                                                             Deficit
                                                                                                            Accumulated
                                           Treasury Stock                Common Stock          Common       During the
                                      --------------------------    -----------------------    Stock        Exploration
                                       # of Shares     Amount       # of Shares   Amount       Warrants       Stage        Totals
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------
                                                                                                    

Issuance of stock for Assets 7/03               -              -     70,000,000           3             -            -           3
Issuance of stock for Cash 8/03                 -              -      9,000,000     225,450             -            -     225,450
Issuance of stock for Debt 9/03                 -                       115,000     121,828             -            -     121,828
Issuance of stock for Accruals 9/03             -              -        115,000      89,939             -            -      89,939
Issuance of stock for Services 9/03             -              -     31,300,000     125,200             -            -     125,200
Net Loss for year                               -              -              -           -             -     (145,868)   (145,868)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 2003                    -              -    111,298,148   2,821,726             -   (2,819,377)      2,349
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Issuance of stock for cash 3/04                 -              -        181,750      21,071             -            -      21,071
Issuance of stock for cash 4/04                 -              -        217,450      22,598             -            -      22,598
Issuance of stock for cash 5/04                 -              -        254,956      34,669             -            -      34,669
Issuance of stock for cash 6/04                 -              -        694,649      96,306             -            -      96,306
Issuance of stock for cash 7/04                 -              -        157,649      21,421             -            -      21,421
Issuance of stock for cash 8/04                 -              -         57,000       5,133             -            -       5,133
Issuance of stock for cash 9/04                 -              -      1,174,500      81,472             -            -      81,472
Issuance of Common Stock Warrants               -              -              -           -     1,200,000            -   1,200,000
Net Loss for Year                               -              -              -           -             -   (1,509,068) (1,509,068)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 2004                                        114,036,102   3,104,396     1,200,000   (4,328,445)    (24,049)
                                                                    -----------  ----------   -----------   ----------    ----------



                                                  See Accountants' Review Report
                                                                F-7



                                                             XSUNX, INC.
                                                    (A Development Stage Company)
                                             STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
                                                          December 31, 2005

                                                             (Unaudited)

                                                                                                             Deficit
                                                                                                            Accumulated
                                           Treasury Stock                Common Stock          Common       During the
                                      --------------------------    -----------------------    Stock        Exploration
                                       # of Shares     Amount       # of Shares   Amount       Warrants       Stage        Totals
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------
                                                                                                    

Issuance of stock for cash                      -              -      5,919,537     471,068             -            -     471,068
Issuance of stock for cash                      -              -        300,500      20,067             -            -      20,067
Issuance of stock for services                  -              -         10,000       3,000             -            -       3,000
Issuance of stock for services                  -              -        300,000      24,000             -            -      24,000
Issuance of stock for cash                      -              -        527,000      40,260             -            -      40,260
Issuance of stock for services                  -              -        125,000      10,000             -            -      10,000
Issuance of stock for services                  -              -        114,469      13,827             -            -      13,827
Issuance of stock for collateral       26,798,418              -              -           -             -            -           -
Issuance of stock for loan inducement           -              -      2,544,031     310,117             -            -     310,117
Net Loss for Year                                                             -           -             -   (1,400,839) (1,400,839)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance - September 30, 2005           26,798,418              -    123,876,639   3,996,735     1,200,000   (5,729,284)   (532,549)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Issuance of stock for services                  -              -         40,441       7,500             -            -       7,500
Issuance of Common Stock Warrants               -              -                          -       951,250            -     951,250
Net Loss for Period                             -              -              -           -             -   (1,595,533) (1,595,533)
                                      -----------    -----------    -----------  ----------   -----------   ----------    ----------

Balance December 31, 2005              26,798,418    $         -    123,917,080  $4,004,235   $ 2,151,250  $(7,324,817)$(1,169,332)
                                      ===========    ===========    ===========  ==========   ===========   ==========   ===========


All shares have been adjusted for the 1 for 20 reverse split.





                                                  See Accountants' Review Report
                                                                F-8






                                   XSUNX, INC.
                          (A Development Stage Company)
                             STATEMENT OF CASH FLOWS
                                   (unaudited)
                                                                                                         Feb. 25, 1997
                                                                         Three-Months Ended              (Inception) to
                                                                            December 31,                  December 31,
                                                                 -----------------------------------
                                                                      2005                2004                2005
                                                                 ----------------     --------------    -----------------
Cash Flows from Operating Activities:
                                                                                               
Net Loss                                                         $   (1,595,533)      $   (164,889)     $    (7,324,817)


   Issuance of Common Stock for Services                                   7,500                  -            1,295,884

   Issuance of Common Stock for Loan Inducement                                -                  -              310,117

   Depreciation                                                                -                  -               21,613
  Adjustments to reconcile net loss to cash used in
    operating activities:

   (Increase) Accounts Receivable                                        (8,000)                                 (8,000)

   Decrease (Increase) in Prepaid Expense                              (220,962)                  -            (300,946)

   Increase (Decrease) in Accrued Expenses                                19,780              (155)               65,636

   Increase (Decrease)  in Accounts Payable                             (51,741)           (14,045)               26,636
                                                                 ----------------     --------------    -----------------

Net Cash Flows Used for Operating Activities                         (1,848,956)          (179,089)          (5,913,877)
                                                                 ----------------     --------------    -----------------

Cash Flows from Investing Activities:

    Purchase of Equipment                                                      -                  -            (187,444)

    Purchase of Intangible Assets                                              -                  -             (20,000)
                                                                 ----------------     --------------    -----------------


Net Cash Flows Used for Investing Activities                                   -                  -            (207,444)
                                                                 ----------------     --------------    -----------------

Cash Flows from Financing Activities:

   Proceeds from Notes Payable                                         2,000,000                  -            2,850,000

   Issuance of Common Stock Warrants                                     951,250                  -            2,151,250

   Issuance of Common Stock                                                    -            471,068            2,398,234
                                                                 ----------------     --------------    -----------------

Net Cash Flows Provided by Financing Activities                        2,951,250            471,068            7,399,484
                                                                 ----------------     --------------    -----------------

Net Increase (Decrease) in Cash                                        1,102,294            291,979            1,278,163
                                                                 ----------------     --------------    -----------------


Cash and cash equivalents - Beginning of period                          175,869             37,344                    -
                                                                 ----------------     --------------    -----------------

Cash and cash equivalents - End of period                        $     1,278,163      $     329,323     $      1,278,163
                                                                 ================     ==============    =================

Supplemental Disclosure of Cash Flow Information
   Cash Paid During the Year for:

      Interest                                                   $             -      $           -     $         71,346
                                                                 ================     ==============    =================
      Income Taxes                                               $             -      $           -     $              -
                                                                 ================     ==============    =================

NON-CASH TRANSACTIONS
    Common stock issued in exchange for services
                                                                 $             -      $           -     $      1,237,557
                                                                 ================     ==============    =================

                         See Accountants' Review Report
                                       F-9




                                   XSUNX, INC.
                          (A Development Stage Company
                          NOTES TO FINANCIAL STATEMENTS
                                December 31, 2005
                                   (Unaudited)



NOTE 1 - PRESENTATION OF INTERIM INFORMATION:

In the opinion of the  management of XSUNX,  Inc.,  the  accompanying  unaudited
financial  statements  include all normal  adjustments  considered  necessary to
present fairly the financial position as of December 31, 2005 and the results of
operations  for the  three-months  ended  December 31, 2005 and 2004 and for the
period  February 25, 1997  (inception)  to December 31, 2005, and cash flows for
the  three-months  ended  December  31,  2005 and  2004  and the for the  period
February 25, 1997  (inception)  to December 31,  2005.  Interim  results are not
necessarily indicative of results for a full year.


The financial  statements and notes are presented as permitted by Form 10-Q, and
do not contain certain  information  included in the Company's audited financial
statements and notes for the fiscal year ended September 30, 2005.

NOTE 2 - GOING CONCERN:

The Company's financial statements have been presented on the basis that it is a
going concern, which contemplates the realization of assets and the satisfaction
of liabilities in the normal course of business.

The Company is in the development stage and as of the period ending December 31,
2005, did not have any products for sale, and had not generated any revenue from
sales or other operating  activities.  To date the Company's principal source of
liquidity has been the private  placement of equity  securities and the issuance
of notes payable. As such, the Company's ability to secure additional  financing
on a timely  basis is critical to its ability to stay in business  and to pursue
planned  operational  activities.  The Company's  ability to continue as a going
concern is dependent upon its ability to develop  additional  sources of capital
and  ultimately,  achieve  profitable  operations.  The  accompanying  financial
statements do not include any adjustments  that might result from the outcome of
these uncertainties.

The Company has made  substantial  investments this last year in the development
of intellectual  property assets as part of a  business-restructuring  plan. The
purpose  of these  investments  was to acquire  patented  solar  electric  glass
technology. The Company believes that its patented solar electric technology has
a number  of  marketing  opportunities  in the  multi-billion  dollar  worldwide
architectural glass markets.


                                      F-10








                                   XSUNX, INC.
                          (A Development Stage Company
                          NOTES TO FINANCIAL STATEMENTS
                                December 31, 2005
                                   (Unaudited)



NOTE 3 - EQUITY TRANSACTIONS:


Expanded License and Warrants

Expanded Use License stock warrant  MVSystems,  Inc. - As consideration  for the
grant of an Expanded Use License on October 12, 2005,  granting XsunX additional
benefits  for use of licensed  technologies  and  patents,  XsunX  granted MVS a
warrant (the  "Expanded  Use License  Stock  Warrant") for the purchase of up to
Seven  Million  (7,000,000)  shares of common  stock of XsunX,  the warrant will
expire  five  (5)  years  after  the date of the  grant  and is  subject  to the
following vesting provisions:

     (1)  The Expanded Use License Stock Warrant  allowed for the vesting of one
          million (1,000,000) warrants on the effective date of the agreements.

     (2)  Another  one  million   (1,000,000)   warrants   will  vest  upon  the
          satisfactory  completion  of a Phase  4  development  program  for the
          development of technologies licensed under the Expanded Use License.

     (3)  The balance of five million  (5,000,000)  warrants  will vest upon the
          date the  technologies  licensed  within the  Expanded Use License are
          licensed  to a  third  party  in a bona  fide  arms-length  commercial
          setting.


In December 2005, 4,375,000 warrants were issued to Cornell Capital Partners, LP
at $.15 (3,125,000 warrants) and $.05 (1,250,000 warrants) over market.

The total charged to expense was $951,250 for these warrant issuances.

Issuance of Shares For Services

On or about December 5, 2005 the Company issued 40,441 shares of common stock to
1 consultant as compensation for three months of services that had been rendered
to the company for a period prior to this quarter. The shares were valued at the
average  market price of the Company's  common stock over the three month period
of  services  which was  $0.18559  per share  for a total  compensated  value of
$7,500.


                                      F-11






                                   XSUNX, INC.
                          (A Development Stage Company
                          NOTES TO FINANCIAL STATEMENTS
                                December 31, 2005
                                   (Unaudited)


NOTE 4 - CONVERTIBLE DEBENTURES:

On December 12, 2005, XsunX, Inc.  consummated a Securities  Purchase  Agreement
dated  December 12, 2005 with Cornell  Capital  Partners L.P.  providing for the
sale by the  Company to Cornell of 10%  secured  convertible  debentures  in the
aggregate  principal amount of $5,000,000 (the "Debentures") of which $2,000,000
was advanced immediately as is included in convertible notes payable at December
31, 2005.  The second  installment  of $2,000,000  will be advanced  immediately
prior to the filing by the Company, with the Securities and Exchange Commission,
of a Registration Statement. The last installment of $1,000,000 will be advanced
three days prior to the date the Registration Statement is declared effective by
the Commission.  The Debenture is convertible into shares of Common Stock at the
option of the  Holder at a  conversion  price per share  equal to the  lesser of
$0.38 or 95% of the lowest daily  volume  weighted  average  price of the Common
Stock, as quoted by Bloomberg, LP, for the 30 trading days immediately preceding
the date of  conversion  (the  "Variable  Market  Price").  Unless waived by the
Company, the Holders may not, together with their affiliates,  convert more than
an  aggregate  of  $350,000  in any  30-day  period of  principal  amount of the
Debentures at the Variable Market Price.  Cornell has agreed not to short any of
the shares of Common Stock.

On July 14,  2005,  XSUNX,  Inc.  entered into a Secured  Convertible  Debenture
agreement  with Cornell  Capital  Partners,  LP in the amount of  $400,000.  The
interest shall accrue on the outstanding  principal  balance hereof at an annual
rate equal to twelve  percent (12 %.) This Debenture  shall be convertible  into
shares of Common Stock at the option of the Holder,  with a conversion  price in
effect on any Conversion  Date shall be equal to ten cents ($.10),  which may be
adjusted pursuant to the other terms of this Debenture.

On August 16, 2005,  XSUNX,  Inc.  received an additional  $450,000 from Cornell
Capital  Partners,  LP  with  the  same  interest  and  conversion  rights.  The
Debentures  are  secured  by the assets of the  Company  and mature on the first
anniversary  of the date of issuance and bear interest at the annual rate of 12%
in cash.



















                                      F-12



Item 2. MANAGEMENT'S  DISCUSION AND ANALYSIS OF FINANCIAL  CONDITION AND RESULTS
OF OPERATIONS

CAUTIONARY AND FORWARD LOOKING STATEMENTS

         In addition to statements of historical fact, this Form 10-KSB contains
forward-looking  statements.  The presentation of future aspects of XsunX,  Inc.
("XsunX",  the "Company" or "issuer") found in these  statements is subject to a
number of risks and  uncertainties  that could  cause  actual  results to differ
materially from those reflected in such statements. Readers are cautioned not to
place  undue  reliance  on  these  forward-looking  statements,   which  reflect
management's  analysis  only  as  of  the  date  hereof.  Without  limiting  the
generality of the foregoing,  words such as "may", "will", "expect",  "believe",
"anticipate",  "intend",  or  "could"  or the  negative  variations  thereof  or
comparable terminology are intended to identify forward-looking statements.

         These  forward-looking  statements are subject to numerous assumptions,
risks and  uncertainties  that may cause XsunX's actual results to be materially
different  from  any  future  results  expressed  or  implied  by XsunX in those
statements.  Important  facts that could prevent XsunX from achieving any stated
goals include, but are not limited to, the following:

         Some  of  these  risks  might  include,  but are not  limited  to,  the
following:

     (a)  volatility or decline of the Company's stock price;

     (b)  potential fluctuation in quarterly results;

     (c)  failure of the Company to earn revenues or profits;

     (d)  inadequate  capital to continue or expand its  business,  inability to
          raise additional capital or financing to implement its business plans;

     (e)  failure to commercialize its technology or to make sales;

     (f)  rapid and significant changes in markets;

     (g)  litigation  with or legal claims and  allegations by outside  parties;
          and

     (h)  insufficient revenues to cover operating costs.

         There is no assurance that the Company will be profitable,  the Company
may not be able to  successfully  develop,  manage or market  its  products  and
services,  the Company may not be able to attract or retain qualified executives
and  technology  personnel,  the  Company's  products  and  services  may become
obsolete,  government  regulation may hinder the Company's business,  additional
dilution in outstanding  stock  ownership may be incurred due to the issuance of
more shares,  warrants and stock options,  or the exercise of warrants and stock
options, and other risks inherent in the Company's businesses.

         The  Company   undertakes  no  obligation  to  publicly   revise  these
forward-looking  statements to reflect events or circumstances  that arise after
the date hereof.  Readers should carefully review the factors described in other
documents the Company files from time to time with the  Securities  and Exchange
Commission, including the Quarterly Reports on Form 10-QSB and Annual Reports on
Form 10-KSB  filed by the  Company and any Current  Reports on Form 8-K filed by
the Company.

                                       3




CURRENT OVERVIEW

         XsunX,  Inc. is developing  Power  Glass(TM) - an innovative  thin film
solar technology that is intended to allow glass windows to produce  electricity
from the power of the sun.  This process for producing  electricity  is known as
Photovoltaics.  Photovoltaic  ("PV") is the science of capturing and  converting
solar energy into electricity.

         The Company is focusing its research and product development efforts on
thin film PV devices in an effort to capitalize on what it perceives as cost and
application  diversity  advantages  to current rigid  multi-crystalline  silicon
wafer  technologies.  The  Company's  thin film cell designs  employ  between .2
microns to 1.5 microns of material  thickness as opposed to an  approximate  400
microns  of  material  thickness  for   multi-crystalline   cell  designs.  This
significant  reduction in cell  thickness and  flexibility of the completed cell
structure  leads to the use of "thin film"  terminology  in describing the solar
cell design.

         The product of the Company's development efforts is intended to deliver
two aspects of deliverable  technologies  in the form of an integrated  solution
providing,   a)  commercially  scalable  manufactured  processes  and  equipment
designed  for  the  specific  manufacture  of  the  Company's  thin  film  solar
technologies,  and, b) proprietary thin film solar cell designs that address new
application   opportunities   in  the  growing  field  of  Building   Integrated
Photovoltaics.

         Building  Integrated  Photovoltaics  or  ("BIPV")  allows  photovoltaic
material,  in the form of  photoelectric  panels,  to be  incorporated  into the
design of building materials;  thus,  providing a new and smart way to integrate
additional  sources of power production into the operation of buildings.  As the
BIPV category of the photovoltaic  industry is beginning its growth into the US,
and worldwide  markets,  XsunX intends to positioned  itself as one of the first
companies  dedicated  to the large  scale  commercialization  of BIPV  through a
combination  of  innovation  and patented  thin film  designs and  manufacturing
techniques.

         Through the  successful  commercial  development  of its Power Glass(R)
film, a semi-transparent solar electric glazing process, the Company anticipates
being able to take  advantage  opportunities  to provide a  commercially  viable
method for converting large areas of  architectural  glass into electrical power
producing  systems.  Upon the  completion of its  commercialization  process the
Company  anticipates the majority of revenues to be derived from the sale of its
proprietary manufacturing systems and the licensing of its technologies.

         Management  believes  the  summary  data  presented  herein  is a  fair
presentation of the Company's  results of operations for the periods  presented.
Due to the Company's  change in primary  business  focus in October 2003 and new
business   opportunities   these  historical  results  may  not  necessarily  be
indicative  of results to be expected  for any future  period.  As such,  future
results of the Company may differ significantly from previous periods.

RESULTS OF  OPERATIONS  FOR THE  THREE-MONTH  PERIOD  ENDED  DECEMBER  31,  2005
COMPARED TO THE SAME PERIOD IN 2004

         The Company  generated  $8,000 in revenues in the period ended December
31, 2005 as compared to $0.0 for the same period in
2004.

         The Company incurred  operating  expenses  totaling  $1,566,359 for the
three months  ending  December 31, 2005 compared to $164,987 for the same period
in 2004.  Primary  sources for the increase to operating  expense of  $1,401,369
include:  Research and Development expenses increased by $175,706 to $274,603 as
compared  to $98,897  for the same  period in 2004,  Public  Relations  activity
increased  by $26,163 to $33,352 as  compared  to $7,189 for the same  period in
2004, Legal and Accounting  expenses increased by $24,626 to $33,750 from $9,124
in 2004.  The  increase  in overall  expenses  included  a  one-time  expense of
$420,000 associated with the grant of in-the-money warrants as consideration for
the expansion of licensing and manufacturing rights associated with a technology
sharing  and  license  agreement  granted  to the  Company.  And,  there  was an
additional one-time expense of $531,250 from the grant of in-the-money  warrants
associated with the sale by the Company of 10% secured convertible debentures in
the aggregate  principal amount of $5,000,000.  The Company incurred  additional
one-time cash expenses for loan and  structuring  fees associated with the above
referenced  debenture  totaling  $213,000.  The  $1,566,359  operating  expenses
includes  non-cash charges of $7,500 for the issuance of unregistered  stock for
business development and advisory services in lieu of cash payment for services.

                                       4


         The net  loss  for the  three  months  ending  December  31,  2005  was
($1,595,533)  as compared to a net loss of ($164,889)  for the same period 2004.
The increase of  $1,430,644 in first quarter of this fiscal year includes (i) an
increase in research and  development  expenditures  of $175,706  over the first
quarter in the previous fiscal year which is anticipated to continue to increase
for the  foreseeable  future as the Company  furthers  efforts to  complete  the
commercial   development  of  a  licensable   process  for  the  manufacture  of
semi-transparent  solar  electric  glazing  technologies,  (ii) an  increase  to
General and Administrative  expenses totaling $61,413 representing the continued
increase in costs  associated  with  expansion of the Company's  business  plan,
(iii) $420,000 in expenses associated with the grant of in-the-money warrants as
consideration for the expansion of licensing and manufacturing rights associated
with a technology  sharing and license  agreement  granted to the Company,  (iv)
$744,250 in expenses  associated  with fees resulting from financing  activities
from the sale by the  Company  of a 10%  secured  convertible  debenture  in the
aggregate  principal  amount of $5,000,000 and, (v) $37,177 for accrued interest
expenses.  These  expenses in the first quarter of the current  fiscal year were
all  incurred  in  preparing  to  commercialize  a  licensable  process  for the
manufacture of semi-transparent solar electric glazing technologies.

         The Company  incurred net loses of  ($1,595,533)  and ($164,889) in the
three-month period ended December 31, 2005 and 2004 respectively. The associated
net loss per share was ($.01) in the three-month  period ended December 31, 2005
and nominal in the period in 2004.  The  Company  expects the trend of losses to
continue at an accelerated  rate in future quarters until the Company is able to
begin sales of significance of which there is no assurance.

LIQUIDITY AND CAPITAL RESOURCES

         The  Company had cash at December  31, 2005 of  $1,278,163  and prepaid
expenses in the amount of  $300,964 as compared to cash of $175,869  and prepaid
expenses in the amount of $79,984 as of September  30,  2005.  The Company had a
net working  capital  (deficit) of ($1,355,163) as compared to a working capital
(deficit)  of  ($718,380)  at September  30,  2005.

         For the  three-months  ended December 31, 2005,  the Company's  capital
needs  have  been met  from the  proceeds  of the  sale of  secured  convertible
debentures  made by the  Company.  In July 2005 the  Company  sold a 12% secured
convertible  debenture in the  principal  amount of $850,000 and in December the
Company  sold a 10% secured  convertible  debenture in the  aggregate  principal
amount of $5,000,000 of which the Company had received $2,000,000 as of December
31, 2005. The proceeds from the above sale of debentures  were used primarily to
fund the research and  developments  efforts and  day-to-day  operations  of the
Company and to pay the accrued liabilities associated with these operations.

         We had, at December 31, 2005,  cash and cash  equivalents of $1,587,109
and net working capital (deficit) of ($1,355,163). We anticipate that there will
not be sufficient  cash generated from  operations in the current year necessary
to fund our current and anticipated cash requirements. The Company may engage in
efforts to obtain additional financing from equity and debt placements.

CASH FLOWS

         Cash flow used in operating  activities  during the three-month  period
ended,  December 31, 2005, was  ($1,848,956) as compared to using ($179,089) for
the same period 2004.  The  increase of cash used in  operations  of  $1,669,867
included (i) an increase in research and  development  expenditures of $175,706,
(ii) an  increase  to  General  and  Administrative  expenses  totaling  $61,413
representing  the continued  increase to costs  associated with expansion of the
Company's business plan, (iii) $420,000 in expenses associated with the grant of
in-the-money  warrants as  consideration  for the  expansion  of  licensing  and
manufacturing  rights associated with a technology sharing and license agreement
granted to the Company, (iv) $744,250 in expenses associated with fees resulting
from  financing  activities  from  the  sale  by  the  Company  of  10%  secured
convertible  debentures in the aggregate  principal  amount of  $5,000,000,  (v)
$37,177 for accrued  interest  expenses and, (vi) non-cash charges of $7,500 for
the  issuance  of  unregistered  stock for  business  development  and  advisory
services in lieu of cash payment for services. The value of the stock issued for
services was  determined  by using the average of the last sale closing price as
quoted on the OTCBB over the three month period the services were rendered.

         The Company had net cash flows from financing activities of $2,951,250,
$2,000,000 of which was from  debentures sold and $951,250 was charged as a cost
for issuance of warrants.

                                       5


NEED FOR ADDITIONAL FINANCING

         The Company  anticipates that there will be insufficient cash generated
from  operations  in the current  year  necessary to fund its  anticipated  cash
requirements.   The  Company  has   incurred   operating   deficits   since  its
reorganization  in October  2003,  which are expected to continue  until its new
business  model is fully  developed.  Accordingly,  the Company is  dependent on
raising  additional  capital  necessary  to meet the  Company's  cash  needs for
Research,  Development,  General and Administrative expenses including the costs
of compliance  with the  continuing  reporting  requirements  of the  Securities
Exchange Act of 1934.

        The  Company  has been able to raise  capital in a series of equity and
debt offerings in the past and is actively pursuing additional  financing in the
form of loans or equity placements to cover on going cash needs. There can be no
assurances that the Company will be able to obtain such additional financing, on
terms acceptable to it and at the times required, or at all. Lack of capital may
be a  sufficient  impediment  to  prevent  it  from  accomplishing  the  goal of
commercializing  a licensable  process for the  manufacture of  semi-transparent
solar electric glazing technologies.

         The Company has  registered on Form SB-2,  effective  February 9, 2006,
72,879,263  shares.  The  registration  relates  to the  resale  by the  selling
stockholders  of up to  72,879,263  shares  of our  common  stock.  The  selling
stockholders  may sell common stock from time to time in the principal market on
which  the  stock is  traded at the  prevailing  market  price or in  negotiated
transactions.  The total number of shares sold  herewith  includes the following
shares  owned by or to be issued  to  Cornell  Capital  Partners  LP:  (i) up to
9,520,000  shares  issuable upon conversion of secured  convertible  debentures,
including  interest,  at a fixed conversion price of $0.10 per share; (ii) up to
50,000,000 shares issuable upon conversion of secured convertible  debentures at
a  conversion  price  equal to the  lesser of $0.38 or 95% of the  lowest  daily
volume  weighted  average  price of our  common  stock for the 30  trading  days
immediately  preceding the conversion date; (iii) 4,250,000 shares issuable upon
the exercise of warrants at $0.15 per share; (iv) 2,125,000 shares issuable upon
the  exercise  of warrants at $0.20 per share;  (v)  3,125,000  shares of common
stock issuable upon the exercise of warrants at $0.45 per share;  (vi) 1,250,000
shares of common  stock  issuable  upon the  exercise  of  warrants at $0.55 per
share; and (vii) 2,544,031 shares previously issued.

         We are also including 65,232 shares owned by another shareholder.

         This  registration  may allow  conversion of $5,850,000 in  outstanding
debentures to registered  common  shares and also  registered  shares to further
allow  exercise of  10,750,000  warrants for purchase of shares.  Proceeds  from
warrant exercise, if any, will be received and used by Company.

         Irrespective   of  whether  the  Company's  cash  assets  prove  to  be
inadequate to meet the Company's  operational  needs,  the Company might seek to
compensate providers of services by issuances of stock in lieu of cash.

GOING CONCERN

         The  Company is in the  development  stage and as of the period  ending
December 31, 2005, did not have any products for sale, and had not generated any
revenue  from  sales  or  other  operating  activities.  To date  the  Company's
principal  source  of  liquidity  has  been  the  private  placement  of  equity
securities and the issuance of notes payable.  As such, the Company's ability to
secure additional financing on a timely basis is critical to its ability to stay
in business and to pursue planned operational activities.

         Based  on the  foregoing  and the  Company's  history  of  losses,  the
Company's financial  statements for the six-month period ended December 31, 2005
include a going concern  opinion from its outside  auditors,  which stated there
"is  substantial  doubt"  about our  ability to continue  operating  as a "going
concern."


                                       6


Item 3. CONTROLS AND PROCEDURES

         The Company's Chief  Executive  Officer and Chairman have evaluated the
effectiveness of the Company's disclosure controls and procedures (as defined in
Rules  13a-15(e) and  15d-15(e)  under the  Securities  Exchange Act of 1934, as
amended) as of the end of the period covered by this quarterly report and, based
on this evaluation,  have concluded that the disclosure  controls and procedures
are effective.

         There have been no  changes  in the  Company's  internal  control  over
financial reporting that occurred during the Company's first fiscal quarter that
has  materially  affected,  or is reasonably  likely to materially  affect,  the
Company's internal control over financial reporting.


                           PART II - OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

         None.


Item 2. CHANGES IN SECURITIES

Expanded License and Warrants

         Expanded Use License stock warrant  MVSystems,  Inc. - As consideration
for the grant of an Expanded  Use License on October 12,  2005,  granting  XsunX
additional benefits for use of licensed technologies and patents,  XsunX granted
MVS a warrant (the "Expanded Use License Stock  Warrant") for the purchase of up
to Seven Million  (7,000,000)  shares of common stock of XsunX, the warrant will
expire  five  (5)  years  after  the date of the  grant  and is  subject  to the
following vesting provisions:

     (1)  The Expanded Use License Stock Warrant  allowed for the vesting of one
          million (1,000,000) warrants on the effective date of the agreements.

     (2)  Another  one  million   (1,000,000)   warrants   will  vest  upon  the
          satisfactory  completion  of a Phase  4  development  program  for the
          development of technologies licensed under the Expanded Use License.

     (3)  The balance of five million  (5,000,000)  warrants  will vest upon the
          date the  technologies  licensed  within the  Expanded Use License are
          licensed  to a  third  party  in a bona  fide  arms-length  commercial
          setting.


Funding Agreement

         On December 12, 2005,  XsunX,  Inc.  consummated a Securities  Purchase
Agreement dated December 12, 2005 with Cornell Capital  Partners L.P.  providing
for the sale by the Company to Cornell of 10% secured convertible  debentures in
the  aggregate  principal  amount  of  $5,000,000  (the  "Debentures")  of which
$2,000,000 was advanced  immediately.  The second installment of $2,000,000 will
be advanced immediately prior to the filing by the Company,  with the Securities
and Exchange Commission,  of a Registration  Statement.  The last installment of
$1,000,000  will be  advanced  three  days  prior to the  date the  Registration
Statement is declared effective by the Commission.  The Debenture is convertible
into shares of Common  Stock at the option of the Holder at a  conversion  price
per  share  equal  to the  lesser  of $0.38 or 95% of the  lowest  daily  volume
weighted average price of the Common Stock, as quoted by Bloomberg,  LP, for the
30 trading days  immediately  preceding  the date of conversion  (the  "Variable
Market Price"). Unless waived by the Company, the Holders may not, together with
their  affiliates,  convert  more than an  aggregate  of  $350,000 in any 30-day
period of  principal  amount of the  Debentures  at the Variable  Market  Price.
Cornell has agreed not to short any of the shares of Common Stock

         Under the  Purchase  Agreement,  the  Company  also  issued to  Cornell
five-year warrants to purchase 3,125,000 and 1,250,000 shares of Common Stock at
$0.45 and $0.55, respectively (collectively, the "Warrants").

                                       7


Termination of Distribution Agreement

         In July 2005, in association with the sale of a Convertible 12% Secured
Debenture, the Company entered into a Standby Equity Distribution Agreement (the
"Distribution  Agreement") with an investor  providing for the sale and issuance
of up to  $10,000,000 of Common Stock over a period of up to 24 months after the
signing of the Distribution Agreement. The Company agreed to file a registration
statement   registering   the  Common  Stock   issuable  upon  sales  under  the
Distribution Agreement and for the underlying shares associated with the sale of
a  Convertible  12% Secured  Debenture.  On August 17, 2005 the Company  filed a
registration  statement  with the U.S.  Securities  and Exchange  Commission  in
relation to these  agreements.  On December 9, 2005 the Company and the investor
agreed to the  termination of the  Distribution  Agreement and withdrawal of the
registration  statement  as  part  of a  subsequent  financing  agreement,  (see
"Funding Agreement" above). No shares were sold under the Distribution Agreement
prior to its termination.

Issuance of Shares For Services

         On or about December 5, 2005 the Company issued 40,441 shares of common
stock pursuant to Rule 144 of the Act to 1 consultant as compensation  for three
months of services that had been rendered to the company for the periods between
July 7, 2005 and October 6, 2005.  The shares were valued at the average  market
price of the  Company's  common  stock over the three  month  period of services
which was $0.18559 per share for a total compensated value of $7,500.00.


Item 3. DEFAULTS UPON SENIOR SECURITIES

         None.

Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

         None.


Item 5. OTHER INFORMATION

         None.

Item 6. EXHIBITS AND REPORTS ON FORM 8-K

         A. Exhibits:

               31.1 Section 302 Sarbanes-Oxley Certification

               32.1 Section 906 Sarbanes-Oxley Certification

         B. Reports on Form 8-K:

               Form 8-K Report filed on October 17, 2005.

               Form 8-K Report filed on October 28, 2005.

               Form 8-K Report filed on December 12, 2005.









                                       8



SIGNATURES

Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934, as amended, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.


Dated: February 21, 2006                    XSUNX, INC.

                                            By:  /s/ Tom M. Djokovich
                                            ------------------------------------
                                            Tom M. Djokovich, Chief Executive
                                            Officer, President, and acting Chief
                                            Financial Officer



Pursuant to the  requirements  of Section 12 of the  Securities  Exchange Act of
1934,  the  registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.



By:  /s/ Tom M. Djokovich                             Dated: February 21, 2006
---------------------------
Director, President, CEO and acting CFO





                                       9